ORMP
Price
$2.37
Change
-$0.00 (-0.00%)
Updated
Dec 23, 11:34 AM (EDT)
65 days until earnings call
TRAW
Price
$5.43
Change
+$0.10 (+1.88%)
Updated
Dec 20, 04:59 PM (EDT)
Ad is loading...

ORMP vs TRAW

Header iconORMP vs TRAW Comparison
Open Charts ORMP vs TRAWBanner chart's image
Oramed Pharmaceuticals
Price$2.37
Change-$0.00 (-0.00%)
Volume$600
CapitalizationN/A
Traws Pharma
Price$5.43
Change+$0.10 (+1.88%)
Volume$100
CapitalizationN/A
ORMP vs TRAW Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. TRAW commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and TRAW is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ORMP: $2.37 vs. TRAW: $5.02)
Brand notoriety: ORMP and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 66% vs. TRAW: 311%
Market capitalization -- ORMP: $95.94M vs. TRAW: $15.19M
ORMP [@Biotechnology] is valued at $95.94M. TRAW’s [@Biotechnology] market capitalization is $15.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, ORMP is a better buy in the long-term than TRAW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 3 TA indicator(s) are bullish while TRAW’s TA Score has 7 bullish TA indicator(s).

  • ORMP’s TA Score: 3 bullish, 7 bearish.
  • TRAW’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -4.05% price change this week, while TRAW (@Biotechnology) price change was +7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ORMP is expected to report earnings on Feb 26, 2025.

TRAW is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($95.9M) has a higher market cap than TRAW($15.2M). ORMP YTD gains are higher at: 2.597 vs. TRAW (-73.069). ORMP has higher annual earnings (EBITDA): 9.44M vs. TRAW (-24.08M). ORMP has more cash in the bank: 142M vs. TRAW (5.41M). TRAW has higher revenues than ORMP: TRAW (226K) vs ORMP (0).
ORMPTRAWORMP / TRAW
Capitalization95.9M15.2M631%
EBITDA9.44M-24.08M-39%
Gain YTD2.597-73.069-4%
P/E Ratio21.64N/A-
Revenue0226K-
Total Cash142M5.41M2,625%
Total Debt429KN/A-
FUNDAMENTALS RATINGS
ORMP vs TRAW: Fundamental Ratings
ORMP
TRAW
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
85100
PRICE GROWTH RATING
1..100
5065
P/E GROWTH RATING
1..100
48100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (32) in the Biotechnology industry is somewhat better than the same rating for ORMP (67) in the Pharmaceuticals Other industry. This means that TRAW’s stock grew somewhat faster than ORMP’s over the last 12 months.

TRAW's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that TRAW’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (85) in the Pharmaceuticals Other industry is in the same range as TRAW (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to TRAW’s over the last 12 months.

ORMP's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as TRAW (65) in the Biotechnology industry. This means that ORMP’s stock grew similarly to TRAW’s over the last 12 months.

ORMP's P/E Growth Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for TRAW (100) in the Biotechnology industry. This means that ORMP’s stock grew somewhat faster than TRAW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTRAW
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
75%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 6 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLNH0.37N/A
+1.21%
Planet 13 Holdings Inc.
LZAGF587.152.77
+0.47%
Lonza Group AG
RTMVY16.48-0.07
-0.42%
Rightmove Plc
JRONY37.66-0.17
-0.45%
Jeronimo Martins, SGPS, SA
XTRAF0.32-0.01
-1.58%
XTRACT ONE TECHNOLOGIES INC.

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.82%
BPMC - ORMP
44%
Loosely correlated
+1.36%
BTAI - ORMP
44%
Loosely correlated
+8.12%
INO - ORMP
44%
Loosely correlated
-0.27%
MBIO - ORMP
44%
Loosely correlated
+1.64%
VERV - ORMP
44%
Loosely correlated
+11.24%
More

TRAW and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRAW has been loosely correlated with MDGL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TRAW jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRAW
1D Price
Change %
TRAW100%
-5.90%
MDGL - TRAW
39%
Loosely correlated
+5.12%
CYTK - TRAW
36%
Loosely correlated
+4.56%
ORMP - TRAW
34%
Loosely correlated
-4.82%
SNPX - TRAW
32%
Poorly correlated
+19.69%
AXON - TRAW
32%
Poorly correlated
+2.60%
More